Radware Survey Finds Nearly Half of Companies Have Suffered a Data Breach in the Past Year

Substantial Rise in Bot-Driven Internet Traffic Presents a Glaring Blind Spot for IT Security As 79% of Organizations Can’t Tell For Certain If Web Traffic Comes From Humans Or Bots

MAHWAH, N.J., Nov.

RedHill Biopharma Announces Closing of Public Offering of its American Depositary Shares

TEL-AVIV, Israel and RALEIGH, N.C., Nov. 13, 2017 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal and inflammatory diseases and cancer, today announced the closing of its previously announced underwritten public offering of 4,090,909 American Depositary Shares (“ADSs”), each representing ten of its ordinary shares, at a public offering price of $5.50 per ADS.

RedHill Biopharma Reports 2017 Third Quarter Financial Results

  • RedHill maintains a debt-free balance sheet with $39.6 million in cash1 at the end of the third quarter of 2017
  • In addition, an underwritten public offering of the Company’s American Depositary Shares (ADSs) is scheduled to be closed today, November 13, 2017, subject to customary terms and conditions, for aggregate net proceeds of approximately $20.6 million, after deducting underwriting discounts and commissions and other offering expenses
  • Net revenues of approximately $1.5 million in Q3/2017 from the promotion of three GI-specialty products in the U.S., Donnatal®, EnteraGam® (launched in June) and Esomeprazole Strontium Delayed-Release Capsules 49.3 mg (launched mid-September)
  • Decrease quarterly cash burn rate and continued revenue growth are expected in 2018
     
  • Increased focus on partnerships and U.S.

Neuralstem Reports Third Quarter 2017 Fiscal Results and Provides Clinical and Business Update

GERMANTOWN, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) — Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, reported its financial results for the three and nine month periods ended September 30, 2017.

AbacusNext Expands Technology-as-a-Service Platform with Acquisition of HotDocs

Pioneer and Global Leader in Document Automation, HotDocs, Becomes Part of the AbacusNext Family of Business Management Solutions

SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) — AbacusNext®, the largest Technology-as-a- Service (TaaS) provider for the professional services industry, is pleased to announce the acquisition of HotDocs, the global leader in document automation.

AbacusNext Expands Technology-as-a-Service Platform with Acquisition of HotDocs

Pioneer and Global Leader in Document Automation, HotDocs, Becomes Part of the AbacusNext Family of Business Management Solutions

SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) — AbacusNext®, the largest Technology-as-a- Service (TaaS) provider for the professional services industry, is pleased to announce the acquisition of HotDocs, the global leader in document automation.

National Energy Services Reunited Corp. to Acquire Gulf Energy SAOC and National Petroleum Services

  • Creates regional oilfield services leader in the Middle East and North Africa (MENA) region
  • Provides platform to accelerate growth and bring new technology to the region
  • Combines experienced management team with deep sector expertise and successful track record through cycles
  • Brings together diverse and strategic group of large institutional investors
  • Forms the first and only NASDAQ-listed national oilfield services company in MENA region

HOUSTON, Nov.